Replies to post #8918 on Momenta Pharmaceuticals, Inc. (MNTA)

[HattieTheWitch]

...according to today’s PR (#msg-75150121), M402 has started a phase-1/2 trial in pancreatic cancer.

Is a proof-of-concept trial (which I understand this to be) something sanctioned/controlled/required by the FDA, or is it simply an investigative procedure for the company to decide whether or not to move forward?

Thank you.

[iwfal]

Competition for M402?

PCYC's Factor VIIa inhibitor for Pancreatic cancer. It may be entirely coincidence, but it is interesting that it is also a clotting actor being used in pancreatic cancer.